PLA2G4B antibody (N-Term)
Quick Overview for PLA2G4B antibody (N-Term) (ABIN927538)
Target
See all PLA2G4B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Mouse (Murine), Rat (Rattus), Cow (Bovine)
-
Purification
- Purified
-
Immunogen
- PLA2 G2 antibody was raised in rabbit using the N terminal of PLA2 2 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
PLA2G4B Blocking Peptide, (ABIN939674), is also available for use as a blocking control in assays to test for specificity of this PLA2G4B antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Alternative Name
- PLA2G4B
-
Background
- This gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Alternative splicing of this gene results in different transcript variants, some of which are candidates for nonsense-mediated decay (NMD). Synonyms: Polyclonal PLA2G4B antibody, Anti-PLA2G4B antibody, phospholipase A2, group IVB, cytosolic antibody, FLJ42498 antibody, HsT16992 antibody, cPLA2-beta antibody.
-
Pathways
- ER-Nucleus Signaling, VEGF Signaling
Target
-